Drug development for the treatment of amyloid lateral sclerosis (ALS) requires an understanding of how genetic mutations lead to the ALS phenotype. Researchers use human induced pluripotent stem cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback